Palvella Therapeutics Inc
(PVLA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 0 | 0 | 19,520 | 20,055 |
| Gross Profit | N/A | N/A | N/A | 19,520 | 20,055 |
| Operating Expenses | 2,908 | 1,759 | -54,897 | 31,327 | 17,992 |
| Operating Income | -2,908 | -1,759 | 13,386 | -11,807 | 2,063 |
| Interest Expense | 971 | 805 | 0 | 0 | 0 |
| Other Income | -293 | 28 | 25,264 | 1,055 | 1,913 |
| Pre-tax Income | -4,172 | -2,536 | 38,650 | -10,752 | 3,976 |
| Net Income Continuous | -4,172 | -2,536 | 38,650 | -10,752 | 3,976 |
| Net Income | $-4,172 | $-2,536 | $38,650 | $-10,752 | $3,976 |
| EPS Basic Total Ops | -2.47 | -1.54 | 21.41 | -8.70 | 3.63 |
| EPS Basic Continuous Ops | -2.36 | -1.43 | 29.79 | -8.70 | 3.63 |
| EPS Diluted Total Ops | -2.47 | -1.54 | 21.40 | -8.70 | 3.62 |
| EPS Diluted Continuous Ops | -2.36 | -1.43 | 29.66 | -8.70 | 3.62 |
| EPS Diluted Before Non-Recurring Items | -2.76 | -3.95 | -4.00 | N/A | N/A |
| EBITDA(a) | $-2,908 | $-1,759 | $54,897 | $-11,068 | $2,821 |